The flow-cytometry-based evaluation of cellular immunity in cases of cutaneous leishmaniasis and healthy controls from the endemic area in southern Israel

REFERENCES

• Ajdary, S., Alimohammadian, M. H., Eslami, M. B., Kemp, K. & Kharazmi, A. (2000). Comparison of the immune profile of nonhealing cutaneous leish-maniasis patients with those with active lesions and those who have recovered from infection. Infection and Immunity, 68, 1760–1764.
   PubMed Web of Science ®Google Scholar
• Akuffo, H., Schurr, E., Andersson, G., Yamaneberhan, T. & Britton, S. (1987). Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differences. Scandinavian Journal of Immunology, 26, 717–721.
   Google Scholar
• Angulo, R. & Fulcher, D. A. (1998). Measurement of Candida-specific blastogenesis: comparison of car-boxyfluorescein succinimidyl ester labelling of T cells, thymidine incorporation, and CD69 expres-sion. Cytometry, 34, 143–151.
   Google Scholar
• Berberich, C., Machado, G., Morales, G., Carrillo, G., Jimenez- Ruiz, A. & Alonso, C. (1998). The expression of the Leishmania infantum KNIP-11 protein is developmentally regulated and stage specific. Biochimka et Biophysica Acta, 1442, 230–237.
   PubMed Web of Science ®Google Scholar
• Biedermann, T., Zimmermann, S., Himmelrich, H., Gumy, A., Egeter, O., Sakrauski, A. K., Seegmuller, I., Voigt, H., Launois, P., Levine, A. D., Wagner, H., Heeg, K., Louis, J. A. & Rocken, M. (2001). IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nature Immunology, 2, 1054–1060.
   Google Scholar
• Chatterjee, M., Jaffe, C. L., Sundar, S., Basu, D., Sen, S. & Mandal, C. (1999). Diagnostic and prognostic potential of a competitive enzyme-linked immuno-sorbent assay for leishmaniasis in India. Clinical and Diagnostic Laboratory Immunology, 6, 550–554.
   PubMedGoogle Scholar
• Costa, R. P., Gollob, K. J., Machado, P. R., Bacellar, O. A., Almeida, R. P., Barral, A., Barral-Netto, M., Carvalho, E. M. & Dutra, W. O. (2003). Adhesion molecule expression patterns indicate activation and recruitment of CD4+ T cells from the lymph node to the peripheral blood of early cutaneous leishma-niasis patients. Immunology Letters, 90, 155–159.
   PubMed Web of Science ®Google Scholar
• Coutinho, S. G., Oliveira, M. P., Da-Cruz, A. M., de Luca, P. M., Mendonca, S. C., Bertho, A. L., Soong, L. & McMahon-Pratt, D. (1996). T-cell responsive-ness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania brazilknsis promastigote antigens: immunologic patterns associated with cure. Experimental Parasitology, 84, 144-155.
   Google Scholar
• Darabi, H., Abolhassani, M., Kariminia, A. & Alimohammadian, M. H. (2002). Expansion of gammadelta T Cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy. Brazilian Journal of Infectious Diseases, 6, 258–262.
   Google Scholar
• El-On, J., Halevy, S., Grunwald, M. & Weinrauch, L. (1992). Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major a double blind control study. Journal of the American Academy of Dermatology, 27,227–231.
   PubMed Web of Science ®Google Scholar
• Follador, I., Araujo, C., Bacellar, O., Araujo, C. B., Carvalho, L. P., Almeida, R. P. & Carvalho, E. M. (2002). Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection., Clinical Infectious Diseases, 34, E54-E58.
   Google Scholar
• Frankenburg, S. & Klaus, S. (1989). Evaluation of a total lymphocyte proliferation assay as a diagnostic tool for cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 499–502.
   PubMed Web of Science ®Google Scholar
• Frankenburg, S., Jonas, F., Gross, A. & Klaus, S. (1993a). Development of in vitro parameters of cell-mediated immunity in the course of human cuta-neous leishmaniasis infection. American Journal of Tropical Medicine and Hygiene, 48,512–518.
   PubMed Web of Science ®Google Scholar
• Frankenburg, S., Gross, A., Jonas, F. & Klaus, S. (1993b). Effect of topical paromomycin on cell-mediated immunity during cutaneous leishmaniasis. International Journal of Dermatology, 32,68–70.
   PubMed Web of Science ®Google Scholar
• Galvao-Castro, B., Sa Ferreira, J. A., Marzochi, K. F., Marzochi, M. C., Coutinho, S. G. & Lambert, P. H. (1984). Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clinical and Experimental Immunology, 56,58–66.
   PubMed Web of Science ®Google Scholar
• Hailu, A. (2002). The use of direct agglutination test (DAT) in serological diagnosis of Ethiopian cuta-neous leishmaniasis. Diagnostic Microbiology and Infectious Disease, 42,251–256.
   PubMed Web of Science ®Google Scholar
• Jensen, A. T., Gaafar, A., Ismail, A., Christensen, C. B., Kemp, M., Hassan, A. M., Kharazmi, A. & Theander, T. G. (1996). Serodiagnosis of cutaneous leishmaniasis: assessment of an enzyme-linked immunosorbent assay using a peptide sequence from gene B protein. American Journal of Tropical Medicine and Hygiene, 55, 490-495.
   Google Scholar
• Louzir, H., Melby, P. C., Ben Salah, A., Marrakchi, H., Aoun, K., Ben Ismail, R. & Dellagi, K. (1998). Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. Journal of Infectious Diseases, 177,1687–1695.
   PubMed Web of Science ®Google Scholar
• Machado, P., Araujo, C., da Silva, A. T., Almeida, R. P., d'Oliveira, A. Jr, Bittencourt, A. & Carvalho, E. M. (2002). Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clinical Infectious Diseases, 34, E69-E73.
   Google Scholar
• Mahmoodi, M., Khamesipour, A., Dowlati, Y., Rafati, S., Momeni, A. Z., Emamjomeh, M., Hejazi, H. & Modabber, F. (2003). Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Clinical and Experimental Immunology, 134, 303–308.
   Google Scholar
• Mosleh, I. M., Saliba, E. K., Al-Khateeb, M. S., Bisharat, Z., Oumeish, O. Y. & Bitar, W. (1995). Serodiagnosis of cutaneous leishmaniasis in Jordan using indirect fluorescent antibody test and the enzyme-linked immunosorbent assay. Acta Tropica, 59, 163–172.
   PubMed Web of Science ®Google Scholar
• Oliveira-Neto, M. P., Pirmez, C., Rangel, E., Schubach, A. & Grimaldi G Jr,. (1988). An outbreak of American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in a periurban area of Rio de Janeiro city, Brazil: clinical and epidemiological studies. Memorias do Institut° Oswaldo Cruz, 83, 427–435.
   PubMedGoogle Scholar
• Rocha, P. N., Almeida, R P., Bacellar, O., de Jesus, A. R., Filho, D. C., Filho, A. C., Barral, A., Coffman, R. L. & Carvalho, E. M. (1999). Down-regulation of ml type of response in early human American cutaneous leishmaniasis. Journal of Infectious Diseases, 180, 1731–1734.
   PubMed Web of Science ®Google Scholar
• Sassi, A., Louzir, H., Ben Salah, A., Mokni, M., Ben Osman, A. & Dellagi, K. (1999). Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clinical Experimental Immunology, 116, 127–132.
   PubMed Web of Science ®Google Scholar
• Sehgal, S., Sinha, R., Mallick, A., Arora, S. K. & Hazra, P. K. (1992). Humoral antibody response in Leishmania tropica infection. Journal of Infection, 24, 311–316
   PubMed Web of Science ®Google Scholar
• Souza, W. J., Sabroza, P. C., Santos, C. S., de Sousa, E., Henrique, M. F. & Coutinho, S. G. (1992). Montenegro skin tests for American cutaneous leishmaniasis carried out on school children in Rio de Janeiro, Brazil: an indicator of transmission risk. Acta Tropica, 52,111–119.
   PubMed Web of Science ®Google Scholar
• Toledo, V. P., Mayrink, W., Gollob, K. J., Oliveira, M. A., Costa, C. A., Genaro, O., Pinto, J. A. & Afonso, L. C. (2001). Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment. Memorias do Institut° Oswaldo Cruz, 96, 89–98.
   PubMed Web of Science ®Google Scholar
• Vanloubbeeck, Y. & Jones, D. E. (2004). The immunology of Leishmania infection and the implica-tions for vaccine development. Annals of the New York Academy of Sciences, 1026, 267–272.
   PubMed Web of Science ®Google Scholar
• Von Stebut, E. & Udey, M. C. (2004). Requirements for ml-dependent immunity against infection with Leishmania major. Microbes and Infection, 6, 1102–1119.
   PubMed Web of Science ®Google Scholar